Geode Capital Management, LLC Bio Cardia, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.38 - $0.68 $1,439 - $2,576	-3,789 Reduced 2.37%	155,859 $63,000
Q4 2023 Feb 13, 2024	BUY	$0.37 - $1.07 $5,362 - $15,507	14,493 Added 9.98%	159,648 $105,000
Q2 2023 Aug 11, 2023	BUY	$1.52 - $2.8 $73,812 - $135,970	48,561 Added 50.27%	145,155 $387,000
Q4 2022 Feb 13, 2023	BUY	$1.61 - $32.1 $6,287 - $125,350	3,905 Added 4.21%	96,594 $201,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $30.3 $317 - $40,117	1,324 Added 1.45%	92,689 $179,000
Q2 2022 Aug 12, 2022	BUY	$17.7 - $32.55 $67,437 - $124,015	3,810 Added 4.35%	91,365 $135,000
Q1 2022 May 13, 2022	BUY	$21.3 - $39.0 $228,549 - $418,470	10,730 Added 13.97%	87,555 $181,000
Q2 2021 Aug 13, 2021	BUY	$48.9 - $74.85 $716,727 - $1.1 Million	14,657 Added 23.58%	76,825 $304,000
Q1 2021 May 12, 2021	BUY	$51.3 - $78.15 $2.03 Million - $3.1 Million	39,611 Added 175.6%	62,168 $269,000
Q4 2020 Feb 12, 2021	BUY	$28.8 - $100.5 $649,641 - $2.27 Million	22,557 New	22,557 $78,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.